Information Provided By:
Fly News Breaks for September 9, 2019
HQY
Sep 9, 2019 | 05:03 EDT
Raymond James analyst Gregory Peters upgraded HealthEquity to Strong Buy from Outperform with a price target of $80, down from $90. The analyst views the company's valuation as attractive following the recent pullback in the shares.